Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed ...
CHICAGO — Elderly patients with glioblastoma multiforme should also be treated with temozolomide added on to radiotherapy, as is the standard of care for this cancer, a new study concludes. The new ...
CLEVELAND and DURHAM, N.C., Nov. 11, 2025 /PRNewswire/ -- GenomOncology today announced a strategic partnership with the Glioblastoma Foundation to transform genomic testing for the nation's most ...
Brussels, Belgium, 8 October 2024. A groundbreaking study 1 led by Dr Monika E. Hegi, MD, PhD and European Organisation for Research and Treatment of Cancer (EORTC) headquarters team (Felix Oppong Msc ...
Therapeutic insights for the aggressive subset of high-grade gliomas (HGG) driven by chromosome 1q32 MDM4-containing amplicon and unmethylated MGMT.
GenomOncology, a global company transforming complex clinical and molecular data into actionable intelligence for precision cancer care, has announced a strategic partnership with the Glioblastoma ...
Here’s what to know about glioblastoma, the aggressive brain cancer that claimed Sophie Kinsella’s life at 55.
When doctors biopsy and treat cancer may be just as important as how they treat it. New research from Erik Herzog, Ph.D., the Viktor Hamburger Distinguished Professor in biology in Arts & Sciences at ...
Professor Asaf Hellman and his research team at the Hebrew University-Hadassah Medical School have unveiled new findings in the realm of methylation-directed regulatory networks. Their study sheds ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback